Axsome Therapeutics reported on November 5 that it acquired Baergic Bio, Inc. from Avenue Therapeutics for $0.3 million. Founded in December 2019, Baergic Bio is a clinical-stage pharmaceutical company that focuses on the development of a pharmaceutical product for the treatment of CNS disorders. Axsome Therapeutics is a […]
The post Axsome Therapeutics Acquires Baergic Bio appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
